15 minute read
Special Ranger Activity
GAINESVILLE MAN INDICTED IN CASE OF STOLEN CATTLE
James Paul Woodard faces second-degree felony charges.
Any small business owner will tell you: it pays to hire the right staff.
Unfortunately, hiring wrong can lead to significant losses.
A Cooke County rancher experienced the latter last year when an employee sold more than $6,000 worth of his boss’ cattle in his girlfriend’s name and pocketed the proceeds.
Texas & Southwestern Cattle Raisers Association Special Ranger Troy McKinney Troy McKinney says James Paul Woodard, a TSCRA Special Ranger District 11 55-year-old from Gainesville, was indicted June 23 by a Cooke County grand jury. He’ll face second-degree felony charges due to the victim’s advanced age. The grand jury determined Woodard’s girlfriend did not have knowledge of the illegal sales.
In October 2020, the victim reached out to the Overbrook Stockyards in Overbrook, Oklahoma, because he had reason to believe some of his cattle had been sold without permission. The auction market’s secretary contacted McKinney, whose investigation proved Woodard had not only sold cattle there, but also at the Decatur Livestock Auction in Decatur. He always put the cattle in his girlfriend’s name to lower suspicion. While the couple owns four cows, it was not enough to produce the number of calves Woodard sold.
McKinney says this case is a good reminder to thoroughly vet potential employees and to continue to monitor both them and your cattle.
“Theft is devastating for a rancher, who is also battling high input costs, weather and market volatility,” McKinney says. “But it’s always a little worse when it’s someone you trusted.” T C
ANNUAL BULL SALE Monday, October 4, 2021
Lunch at 11:30am Sale at 12:30pm
Pete and Angela Case (owners): pete@caseranch.com - (325) 650-6209 angela@caseranch.com - (325) 450-7516 Stephen and Tiffany Loyd: stephen@caseranch.com - (325) 642-5818 tiffany@caseranch.com - (325) 665-8481
Located at: 7350 FM 915, Eldorado, TX 76936 Latitude: 31.0373 Longitude: 100.7316 P.O. Box 240 Mertzon, TX 76941
www.caseranch.com
Visit Case Ranch Herefords on Facebook
(REALLY BIG DEAL) BRD IS AN RBD BRD IS AN RBD
(REALLY BIG DEAL)
Make Baytril® 100 (enro oxacin)
Injectable your rst choice Make Baytril® 100 (enro oxacin) at rst pull. Injectable your rst choice Talk with your veterinarian to learn more. at rst pull. Talk with your veterinarian to learn more.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of Extra-label use of this drug in food-producing animals is prohibited. Cattle a licensed veterinarian. intended for human consumption must not be slaughtered within 28 days from Extra-label use of this drug in food-producing animals is prohibited. Cattle the last treatment. This product is not approved for female dairy cattle 20 months intended for human consumption must not be slaughtered within 28 days from of age or older, including dry dairy cows. Use in these cattle may cause drug the last treatment. This product is not approved for female dairy cattle 20 months residues in milk and/or in calves born to these cows. The effects of enro oxacin of age or older, including dry dairy cows. Use in these cattle may cause drug on cattle or swine reproductive performance, pregnancy and lactation have not residues in milk and/or in calves born to these cows. The effects of enro oxacin been determined. on cattle or swine reproductive performance, pregnancy and lactation have not been determined.
Elanco and the diagonal bar logo are trademarks of Elanco or its af liates. Other product names are trademarks of their respective owners. Elanco and the diagonal bar logo are trademarks of Elanco ©2021 Elanco. PM-US-21-0727. or its af liates.
Other product names are trademarks of their respective owners. ©2021 Elanco. PM-US-21-0727.
100 mg/mL Antimicrobial Injectable Solution
For Subcutaneous use In Beef Cattle, Non-Lactating Dairy Cattle For Intramuscular Or Subcutaneous Use In Swine
Not For Use In Female Dairy Cattle 20 Months Of Age Or Older Or In Calves To Be Processed For Veal
BRIEF SUMMARY:
Before using Baytril® 100, please consult the product insert, a summary of which follows:
CAUTION:
Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.
INDICATIONS:
Cattle - Single-Dose Therapy: Baytril® 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Cattle - Multiple-Day Therapy: Baytril® 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle. Swine: Baytril® 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Baytril® 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.Use within 30 days of first puncture and puncture a maximum of 30 times with a needle or 4 times with a dosage delivery device. Any product remaining beyond these parameters should be discarded.
RESIDUE WARNINGS:
Cattle: Animals intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Swine: Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.
HUMAN WARNINGS:
For use in animals only. Keep out of the reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposures. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. For customer service or to obtain product information, including a Safety Data Sheet, call 1-800-633-3796. For medical emergencies or to report adverse reactions, call 1-800-422-9874.
PRECAUTIONS:
The effects of enrofloxacin on cattle or swine reproductive performance, pregnancy and lactation have not been adequately determined.The long-term effects on articular joint cartilage have not been determined in pigs above market weight.Subcutaneous injection in cattle and swine, or intramuscular injection in swine, can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.Baytril® 100 contains different excipients than other Baytril® products. The safety and efficacy of this formulation in species other than cattle and swine have not been determined.Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures. Quinolone-class drugs have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species. See Animal Safety section for additional information.
ADVERSE REACTIONS:
No adverse reactions were observed during clinical trials.
ANIMAL SAFETY:
In feeder calves, clinical signs including depression, incoordination, muscle fasciculation and inappetance have been observed at higher than approved label dosages. In swine subcutaneous safety studies, incidental lameness of short duration and musculoskeletal stiffness have been observed at higher than approved label dosages.In swine intramuscular safety studies, transient decreases in feed and water consumption were observed after each treatment. Mild, transient, post-treatment injection site swellings were observed in pigs receiving the 37.5 mg/kg BW dose. Injection site inflammation was found on post-mortem examination in all enrofloxacin-treated groups. Baytril® 100 Bayer, the Bayer Cross and Baytril are registered trademarks of Bayer. NADA 141-068, Approved by FDA Bayer HealthCare LLC, Animal Health Division Shawnee Mission, Kansas 66201 U.S.A.
100 mg/mL Antimicrobial Injectable Solution
For Subcutaneous use In Beef Cattle, Non-Lactating Dairy Cattle For Intramuscular Or Subcutaneous Use In Swine
Not For Use In Female Dairy Cattle 20 Months Of Age Or Older Or In Calves To Be Processed For Veal
BRIEF SUMMARY:
Before using Baytril® 100, please consult the product insert, a summary of which follows:
CAUTION:
Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.
INDICATIONS:
Cattle - Single-Dose Therapy: Baytril® 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Cattle - Multiple-Day Therapy: Baytril® 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle. Swine: Baytril® 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Baytril® 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.Use within 30 days of first puncture and puncture a maximum of 30 times with a needle or 4 times with a dosage delivery device. Any product remaining beyond these parameters should be discarded.
RESIDUE WARNINGS:
Cattle: Animals intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Swine: Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.
HUMAN WARNINGS:
For use in animals only. Keep out of the reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposures. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. For customer service or to obtain product information, including a Safety Data Sheet, call 1-800-633-3796. For medical emergencies or to report adverse reactions, call 1-800-422-9874.
PRECAUTIONS:
The effects of enrofloxacin on cattle or swine reproductive performance, pregnancy and lactation have not been adequately determined.The long-term effects on articular joint cartilage have not been determined in pigs above market weight.Subcutaneous injection in cattle and swine, or intramuscular injection in swine, can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.Baytril® 100 contains different excipients than other Baytril® products. The safety and efficacy of this formulation in species other than cattle and swine have not been determined.Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures. Quinolone-class drugs have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species. See Animal Safety section for additional information.
ADVERSE REACTIONS:
No adverse reactions were observed during clinical trials.
ANIMAL SAFETY:
In feeder calves, clinical signs including depression, incoordination, muscle fasciculation and inappetance have been observed at higher than approved label dosages. In swine subcutaneous safety studies, incidental lameness of short duration and musculoskeletal stiffness have been observed at higher than approved label dosages.In swine intramuscular safety studies, transient decreases in feed and water consumption were observed after each treatment. Mild, transient, post-treatment V-04/2016 injection site swellings were observed in pigs receiving the 37.5 mg/kg BW dose. ©2015 Bayer HealthCare LLC Injection site inflammation was found on post-mortem examination in all enrofloxacin-treated groups. Baytril® 100 Bayer, the Bayer Cross and Baytril are registered trademarks of Bayer. NADA 141-068, Approved by FDA Bayer HealthCare LLC, Animal Health Division Shawnee Mission, Kansas 66201 U.S.A.
V-04/2016 ©2015 Bayer HealthCare LLC
IT’S ALL IT’S ALL ABOUT BALANCE. BALANCE.
CONTROL AND TREAT BRD WITH LASTING CONFIDENCE.
Balance your BRD protocol and budget with Increxxa™ (tulathromycin injection) featuring tulathromycin, the macrolide antibiotic you can trust to help your cattle breathe easier by fighting BRD. The addition of Increxxa to the extensive Elanco cattle portfolio provides yet another way to help combat BRD and help optimize herd health, efficiency and profit. As with all Elanco products, you can breathe easier knowing Increxxa is held to the company's uncompromising standards for potency, uniformity and quality.
Indication: Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
IMPORTANT SAFETY INFORMATION (ISI)
Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Increxxa has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. (tulathromycin injection)
Injectable Solution
Antibiotic 100 mg of tulathromycin/mL
For use in beef cattle (including suckling calves), non-lactating dairy cattle (including dairy calves), veal calves, and swine. Not for use in female dairy cattle 20 months of age or older. CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Before using Increxxa, please consult the product insert, a summary of which follows:
INDICATIONS Beef and Non-Lactating Dairy Cattle
BRD – Increxxa Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Increxxa Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis. Foot Rot – Increxxa Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Suckling Calves, Dairy Calves, and Veal Calves
BRD – Increxxa Injectable Solution is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.
DOSAGE AND ADMINISTRATION Cattle
Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight (BW). Do not inject more than 10 mL per injection site. Table 1. Increxxa Cattle Dosing Guide
Animal Weight (Pounds) 100 200 300 400 500 600 700 800 900 1000
Dose Volume (mL)
1.1 2.3 3.4 4.5 5.7 6.8 8.0 9.1 10.2 11.4 See product insert for complete dosing and administration information.
CONTRAINDICATIONS
The use of Increxxa Injectable Solution is contraindicated in animals previously found to be hypersensitive to the drug.
WARNINGS FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. NOT FOR USE IN CHICKENS OR TURKEYS.
RESIDUE WARNINGS
Cattle
Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
PRECAUTIONS Cattle
The e ects of Increxxa on bovine reproductive performance, pregnancy, and lactation have not been determined. Subcutaneous injection can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.
ADVERSE REACTIONS Cattle
In one BRD field study, two calves treated with tulathromycin injection at 2.5 mg/kg BW exhibited transient hypersalivation. One of these calves also exhibited transient dyspnea, which may have been related to pneumonia.
STORAGE CONDITIONS
Store below 25°C (77°F), with excursions up to 40°C (104°F). 100 mL: Use within 2 months of first puncture and puncture a maximum of 67 times. If more than 67 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-o spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use. 250 mL and 500 mL: Use within 2 months of first puncture and puncture a maximum of 100 times. If more than 100 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-o spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.
HOW SUPPLIED
Increxxa (tulathromycin injection) Injectable Solution is available in the following package sizes: 100 mL vial 250 mL vial 500 mL vial To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet, contact Elanco at 1-800-422-9874. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae. Approved by FDA under ANADA # 200-666 Product of China. Manufactured by: Elanco US Inc, Shawnee, KS 66216 Increxxa, Elanco and the diagonal bar logo are trademarks of Elanco or its a liates. ©2021 Elanco. PM-US-21-0268 February, 2021
